0
Article |

Comparison of Sernyl with Other Drugs:  Simulation of Schizophrenic Performance with Sernyl, LSD-25, and Amobarbital (Amytal) Sodium; I. Attention, Motor Function, and Proprioception

GERALD ROSENBAUM, Ph.D.; BERTRAM D. COHEN, Ph.D.; ELLIOT D. LUBY, M.D.; JACQUES S. GOTTLIEB, M.D.; DONALD YELEN, B.A.
AMA Arch Gen Psychiatry. 1959;1(6):651-656. doi:10.1001/archpsyc.1959.03590060113013.
Text Size: A A A
Published online

Study of the pathological mechanisms implicated in schizophrenia has recently been accelerated by the production of model psychoses through the use of Psychotomimetic drugs. Our laboratories have previously reported6 Psychotomimetic effects with Sernyl, l-(l-phenylcyclohexyl) piperidine monohydrochloride. This drug is one of a class of new chemical compounds which function as sensory blocking agents, with anesthetic and sedative properties. It was found to produce severe disturbances in body image, affect, attention, and thinking which closely approximated the primary symptoms of schizophrenia. Depersonalization, feelings of isolation and estrangement, concreteness, hypnagogic states, and repetitive motor behavior occurred in patients following intravenous infusion of this drug.

The present studies were conducted in an attempt to isolate the mechanism responsible for the effects of Sernyl and its relevance to the psychopathology of schizophrenia. A number of psychological functions characteristically associated with the primary pathology of schizophrenia were system

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();